The emerging role and therapeutic implications of bacterial and parasitic deubiquitinating enzymes.

autophagy and apoptosis deubiquitinating enzymes (DUBs) immune responses infection mechanisms ubiquitin

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 27 09 2023
accepted: 03 11 2023
medline: 11 12 2023
pubmed: 11 12 2023
entrez: 11 12 2023
Statut: epublish

Résumé

Deubiquitinating enzymes (DUBs) are emerging as key factors for the infection of human cells by pathogens such as bacteria and parasites. In this review, we discuss the most recent studies on the role of deubiquitinase activity in exploiting and manipulating ubiquitin (Ub)-dependent host processes during infection. The studies discussed here highlight the importance of DUB host-pathogen research and underscore the therapeutic potential of inhibiting pathogen-specific DUB activity to prevent infectious diseases.

Identifiants

pubmed: 38077335
doi: 10.3389/fimmu.2023.1303072
pmc: PMC10703165
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1303072

Informations de copyright

Copyright © 2023 Wehrmann and Vilchez.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Curr Pharm Des. 2013;19(18):3234-47
pubmed: 23151130
Semin Cell Dev Biol. 2022 Dec;132:230-241
pubmed: 35177348
Microbes Infect. 2018 Oct - Nov;20(9-10):552-559
pubmed: 29109017
Cell Death Differ. 2017 Sep;24(9):1621-1631
pubmed: 28574503
Annu Rev Biochem. 2017 Jun 20;86:159-192
pubmed: 28498721
Drug Discov Today. 2018 Dec;23(12):1974-1982
pubmed: 29864528
J Biosci. 2006 Mar;31(1):137-55
pubmed: 16595883
J Immunol. 2010 May 1;184(9):5160-71
pubmed: 20335533
Front Microbiol. 2011 Jul 04;2:145
pubmed: 21772836
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15090-5
pubmed: 26598703
BMB Rep. 2016 Aug;49(8):424-30
pubmed: 27418283
Cell Rep. 2020 Sep 8;32(10):108107
pubmed: 32905772
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4864-9
pubmed: 19273841
Nat Commun. 2020 Jun 2;11(1):2751
pubmed: 32488130
Nature. 2021 Jun;594(7861):111-116
pubmed: 34012115
Elife. 2020 Nov 02;9:
pubmed: 33136002
Traffic. 2010 May;11(5):626-36
pubmed: 20163571
J Immunol. 2012 Jul 15;189(2):924-34
pubmed: 22685311
Cell Microbiol. 2016 Mar;18(3):330-9
pubmed: 26762760
Cell Death Differ. 2021 Feb;28(2):473-492
pubmed: 33441937
Hum Mol Genet. 2005 Dec 1;14(23):3751-7
pubmed: 16251197
Nat Rev Drug Discov. 2018 Jan;17(1):57-78
pubmed: 28959952
Curr Opin Microbiol. 2017 Feb;35:16-22
pubmed: 27907841
Biochem J. 2016 Aug 15;473(16):2453-62
pubmed: 27515257
Mol Cell. 2020 Jan 2;77(1):164-179.e6
pubmed: 31732457
PLoS One. 2007 Apr 18;2(4):e381
pubmed: 17440617
Nat Commun. 2020 May 11;11(1):2343
pubmed: 32393759
Front Immunol. 2021 Oct 11;12:742542
pubmed: 34707613
Nature. 2013 Sep 26;501(7468):512-6
pubmed: 24005326
Front Cell Infect Microbiol. 2017 Aug 28;7:384
pubmed: 28971069
Commun Biol. 2022 Feb 8;5(1):114
pubmed: 35136173
PLoS One. 2023 Feb 9;18(2):e0281587
pubmed: 36758031
Oncogene. 2006 Oct 30;25(51):6758-80
pubmed: 17072327
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23518-23526
pubmed: 31690664
Elife. 2017 Mar 28;6:
pubmed: 28347402
Mol Cell. 2016 Jul 21;63(2):261-276
pubmed: 27425412
Curr Opin Microbiol. 2014 Feb;17:46-52
pubmed: 24581692
Biochim Biophys Acta. 2016 Dec;1863(12):3148-3159
pubmed: 27742471
Trends Immunol. 2017 Mar;38(3):194-205
pubmed: 28073693
Mol Cell. 2022 Jan 6;82(1):15-29
pubmed: 34813758
J Cell Sci. 2017 Jun 15;130(12):1985-1996
pubmed: 28476939
Nat Rev Immunol. 2013 Oct;13(10):722-37
pubmed: 24064518
J Biol Chem. 2016 Dec 9;291(50):25853-25863
pubmed: 27789710
Cell Mol Life Sci. 2022 Aug 1;79(8):461
pubmed: 35913642
Int J Mol Sci. 2020 Mar 16;21(6):
pubmed: 32187990
Nature. 2018 May;557(7707):729-733
pubmed: 29795346
Biochem Soc Trans. 2019 Dec 20;47(6):1857-1866
pubmed: 31845741
Cells. 2022 Feb 05;11(3):
pubmed: 35159365
Cell Res. 2017 Jul;27(7):865-881
pubmed: 28497808
Nat Microbiol. 2019 Aug;4(8):1282-1293
pubmed: 31110362
EMBO J. 2007 Jan 24;26(2):436-47
pubmed: 17183367
Annu Rev Cell Dev Biol. 2014;30:79-109
pubmed: 25103867
Nature. 2021 Aug;596(7871):285-290
pubmed: 34321666
EMBO Rep. 2009 May;10(5):466-73
pubmed: 19373254
Infect Immun. 2015 Sep;83(9):3506-14
pubmed: 26099583
Cell Death Differ. 2021 Feb;28(2):557-569
pubmed: 33473179
Nat Microbiol. 2018 Dec;3(12):1377-1384
pubmed: 30397340
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3502-7
pubmed: 17360673
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2217602120
pubmed: 36893270
Cell Microbiol. 2018 Jul;20(7):e12840
pubmed: 29543380
RSC Chem Biol. 2021 Jul 29;2(5):1509-1519
pubmed: 34704056
Science. 2012 Nov 23;338(6110):1072-6
pubmed: 23112293
PLoS Pathog. 2016 May 27;12(5):e1005653
pubmed: 27232334
Cell Host Microbe. 2019 Oct 9;26(4):551-563.e6
pubmed: 31540829
Front Mol Biosci. 2022 Sep 19;9:1008175
pubmed: 36200073
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):
pubmed: 33479176
Nat Cell Biol. 2016 May 27;18(6):579-86
pubmed: 27230526
Nat Immunol. 2015 Dec;16(12):1253-62
pubmed: 26390156

Auteurs

Markus Wehrmann (M)

Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Institute for Integrated Stress Response Signaling, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.

David Vilchez (D)

Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Institute for Integrated Stress Response Signaling, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Institute for Genetics, University of Cologne, Cologne, Germany.

Classifications MeSH